Position in CADL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,010,934
-$465,097 QoQ
Shares Held
818,558
+3.3% QoQ
Ownership
1.12%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 23.413124054740166.ToString("F0")%
Shared 0.ToString("F0")%
None 76.58687594525983.ToString("F0")%
Common Shares in CADL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,288,856,014 across 423 Biotechnology names. CADL ranks #208 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in CADL
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,010,934 | 818,558 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,476,031 | 792,218 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $3,512,706 | 688,766 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,299,013 | 651,979 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,183,232 | 563,404 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $4,869,210 | 560,969 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,409,594 | 492,005 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,931,347 | 472,798 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $43,608 | 27,600 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $40,572 | 27,600 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $25,392 | 27,600 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $34,776 | 27,600 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $37,260 | 27,600 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $49,404 | 27,600 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $86,664 | 27,600 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $89,424 | 27,600 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $140,484 | 27,600 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $208,012 | 26,600 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $288,344 | 26,600 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||